Fight for Insulin Cost Cap; Hormone Predicts Osteoporosis; 3% Obesity Jump in 2020
(MedPage Today) -- The Endocrine Society released a statement praising proposed policy changes that would cap insulin costs at just $35 a month for patients.
Though not everyone is in favor. Voting "no" to this bill, Rep. Matt Gaetz (R-Fla.) argued... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 6, 2022 Category: Endocrinology Source Type: news
Is Q-CT the Gold Standard for Detecting Spinal Osteoporosis? Is Q-CT the Gold Standard for Detecting Spinal Osteoporosis?
Dual-energy X-ray absorptiometry is currently considered as the gold standard for the evaluation of spinal osteoporosis, but could Q-CT provide a better alternative?Spine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 6, 2022 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Prevalence and influencing factors of spinal cord injury-related osteoporosis and fragility fractures in Thai people with chronic spinal cord injury: a cross-sectional, observational study - Mahitthiharn K, Kovindha A, Kaewchur T, Morse LR, Pattanakuhar S.
OBJECTIVE: To investigate the prevalence and influencing factors of spinal cord injury (SCI)-related osteoporosis and fragility fractures in Thai people with chronic spinal cord injury. DESIGN: A cross-sectional, observational study. SETTING: Outpa... (Source: SafetyLit)
Source: SafetyLit - April 6, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
New treatment for osteoporosis
Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture are set to benefit from a new treatment – romosozumab – after NICE recommended it for people after menopause in final draft guidance published by NICE. (Source: NHS Networks)
Source: NHS Networks - April 5, 2022 Category: UK Health Source Type: news
Levels of a certain hormone could predict or detect bone loss in premenopausal women
Physicians may be able to determine if menopause-related bone loss is already in progress or about to begin by measuring the level of a hormone that declines as women approach their final menstrual period, new UCLA research finds.The findings could help physicians determine when, and how, to treat bone loss in women as they age before that bone loss causes significant health issues, according to the study. Specifically, the study found that for women 42 and older who are not yet postmenopausal, levels of anti-Mullerian hormone, or AMH, can be used to determine if they are experiencing, or about to experience, bone loss rel...
Source: UCLA Newsroom: Health Sciences - April 4, 2022 Category: Universities & Medical Training Source Type: news
